Dobutamine EP Impurity A | CAS 51-61-6 - Request Quote
Dobutamine EP Impurity A
| SZ CAT No: | SZ-D095002 |
| CAS No | 51-61-6 |
| Mol.F. | C8H11NO2 |
| Mol.Wt. | 153.2 |
| Inv. Status | In Stock |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dobutamine EP Impurity A is chemically 4-(2-aminoethyl)benzene-1,2-diol (as per EP). It is also known as Dopamine (EP). Dobutamine EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Dobutamine EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dobutamine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 51-61-6
Purchase 51-61-6
Order 51-61-6
Enquire 51-61-6
price of 51-61-6
51-61-6 Supplier
51-61-6 Manufacturer
51-61-6 Exporter
buy high quality Dobutamine EP Impurity A
Purchase Dobutamine EP Impurity A
Dobutamine EP Impurity A suppliers
Dobutamine EP Impurity A manufacturers
Dobutamine EP Impurity A price
Order Dobutamine EP Impurity A
Enquire Dobutamine EP Impurity A
Dobutamine EP Impurity A cost
Dobutamine EP Impurity A Supplier
Dobutamine EP Impurity A Distributor
Dobutamine EP Impurity A for Method Validation
Dobutamine Reference Standard
Dobutamine EP Impurity A for ANDA Filing
Dobutamine EP Impurity A for Forced Degradation Studies
Dobutamine EP Impurity A Identification Standards
Dobutamine EP Impurity A for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


